Patent US3183294A successfully refreshed from Google Patents.
Patent US4233401A successfully refreshed from Google Patents.
US4233401A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Antienzyme homogeneous competitive binding assay
Assignee: Siemens Healthcare Diagnostics GmbH Germany
•
Filing: 1977-07-14
•
Granted: 1980-11-11
•
Expires: 1997-07-14
Abstract
Abstract Methods and reagent combinations are provided for competitive protein binding assays for determining a member of an immunological pair (ligand and receptor) whereby an enzyme-ligand conjugate is employed in combination with an enzyme inhibitor, conveniently an antibody to said enzyme. When ligand is the analyte, receptor for ligand is also included in the assay medium, while supplemental amounts of receptor need not be added when receptor is the analyte. The assay is carried out in an aqueous buffered medium, normally at constant temperature, by combining in the assay medium the unknown sample suspected of containing the analyte, enzyme-bound-ligand, ligand receptor (antiligand), enzyme inhibitor (antienzyme), and enzyme substrates, and the enzymatic activity in the assay medium determined. By comparing the observed enzymatic activity with an unknown to the enzymatic activity observed in an assay medium with a known amount of analyte, the amount of analyte can be quantitatively determined. Kits are provided having matched amounts of enzyme-bound-ligand, antienzyme and, when appropriate, antiligand for use in the subject assay.
Inventors
- 👤 Robert A. Yoshida
- 👤 Edward T. Maggio
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 16:07
CPC Classifications
C; C07; C07J; C07J41/00; C07J41/0005; C07J41/0016; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/536; G01N33/542; Y; Y10; Y10S; Y10S435/00; Y10S435/81; Y10S435/963
Claims Analysis
Total Claims: 26
Claim 1
Independent Claim
121 words
A method for determining the presence in a sample of an analyte which is a member of an immunological pair consisting of ligand and ligand receptor which comprises: combining in an aqueous medium: (A) said sample; (B) enzyme-bound-ligand which retains a substantial proportion of its activity when bound to receptor; (C) ligand receptor, when ligand is the analyte, wherein said receptor is capable of specifically binding to said ligand and said enzyme-bound-ligand; and (D) enzyme inhibitor, of at least about 2,000 molecular weight wherein said inhibitor is impeded from inhibiting said enzyme-bound-ligand, when receptor is bound to enzyme-bound-ligand; and determining the enzymatic activity in said medium as compared to the enzymatic activity in a medium having a known amount of analyte.
Claim 2
Independent Claim
121 words
A method for determining the presence in a sample of an analyte which is a member of an immunological pair consisting of ligand and ligand receptor which comprises: combining in an aqueous medium: (A) said sample; (B) enzyme-bound-ligand which retains a substantial proportion of its activity when bound to receptor; (C) ligand receptor, when ligand is the analyte, wherein said receptor is capable of specifically binding to said ligand and said enzyme-bound-ligand; and (D) enzyme inhibitor, of at least about 2,000 molecular weight wherein said inhibitor is impeded from inhibiting said enzyme-bound-ligand, when receptor is bound to enzyme-bound-ligand; and determining the enzymatic activity in said medium as compared to the enzymatic activity in a medium having a known amount of analyte.
Claim 3
Dependent Claim
35 words
A method according to claim 1, wherein said aqueous medium is at a pH in the range of about 5 to 10 and at a temperature in the range from about 10° to 50° C.
Claim 4
Dependent Claim
27 words
A method according to claim 2, wherein in a first step, said sample, enzyme-bound-ligand and antiligand are combined; and in a second step, enzyme inhibitor is added.
Claim 5
Dependent Claim
34 words
A method according to claim 1, wherein in a first step, said sample and ligand receptor are combined; in a second step enzyme-bound-ligand is added; and in a third step enzyme inhibitor is added.
Claim 6
Dependent Claim
14 words
A method according to claim 1, wherein said enzyme inhibitor is a reversible inhibitor.
Claim 7
Dependent Claim
13 words
A method according to claim 5, wherein said reversible inhibitor is an antienzyme.
Claim 8
Dependent Claim
14 words
A method according to claim 1, wherein said enzyme inhibitor is an irreversible inhibitor.
Claim 9
Dependent Claim
19 words
A method according to claim 7, wherein said irreversible inhibitor is a substrate for the enzyme of said enzyme-bound-ligand.
Claim 10
Dependent Claim
20 words
A method according to claim 1, wherein said analyte is a ligand of from about 5,000 to 1,000,000 molecular weight.
Claim 11
Dependent Claim
21 words
A method according to claim 9, wherein said ligand is a poly(amino acid) of from about 5,000 to 600,000 molecular weight.
Claim 12
Dependent Claim
20 words
A method according to claim 1, wherein said analyte is a ligand of from about 125 to 5,000 molecular weight.
Claim 13
Independent Claim
108 words
A method for determining the presence in a sample of a ligand which comprises: combining in an aqueous medium: (A) said sample; (B) enzyme-bound-ligand which retains a substantial proportion of its activity when bound to receptor; (C) ligand receptor, wherein said receptor is capable of specifically binding to said ligand and said enzyme-bound-ligand; and (D) antienzyme, wherein said antienzyme inhibits said enzyme-bound-ligand when bound to said enzyme and is impeded from binding to the enzyme of said enzyme-bound-ligand, when ligand receptor is bound to enzyme-bound-ligand; and determining the enzymatic activity in said medium as compared to the enzymatic activity in a medium having a known amount of ligand.
Claim 14
Independent Claim
108 words
A method for determining the presence in a sample of a ligand which comprises: combining in an aqueous medium: (A) said sample; (B) enzyme-bound-ligand which retains a substantial proportion of its activity when bound to receptor; (C) ligand receptor, wherein said receptor is capable of specifically binding to said ligand and said enzyme-bound-ligand; and (D) antienzyme, wherein said antienzyme inhibits said enzyme-bound-ligand when bound to said enzyme and is impeded from binding to the enzyme of said enzyme-bound-ligand, when ligand receptor is bound to enzyme-bound-ligand; and determining the enzymatic activity in said medium as compared to the enzymatic activity in a medium having a known amount of ligand.
Claim 15
Dependent Claim
34 words
A method according to claim 12, wherein said aqueous medium is at a pH of from about 6 to 9 and at a temperature in the range of from about 10° to 50° C.
Claim 16
Dependent Claim
27 words
A method according to claim 13, wherein said ligand is an haptenic molecule of from about 125 to 2,000 molecular weight and said enzyme is glucose-6-phosphate dehydrogenase.
Claim 17
Dependent Claim
11 words
A method according to claim 14, wherein said ligand is digoxin.
Claim 18
Dependent Claim
11 words
A method according to claim 14, wherein said ligand is triiodothyronine.
Claim 19
Independent Claim
118 words
A method for determining the presence in a sample of a ligand which comprises: combining in an aqueous medium: (A) said sample; (B) enzyme-bound-ligand, which retains a substantial proportion of its activity when bound to ligand receptor; (C) ligand receptor, wherein said receptor is capable of specifically binding to said ligand and said enzyme-bound-ligand; and (D) enzyme inhibitor, of at least about 5,000 molecular weight which is an enzyme substrate which reacts with said enzyme to inhibit said enzyme and is impeded from reacting with said enzyme when ligand receptor is bound to said enzyme-bound-ligand; and determining the enzymatic activity in said medium as compared to the enzymatic activity in a medium having a known amount of ligand.
Claim 20
Independent Claim
118 words
A method for determining the presence in a sample of a ligand which comprises: combining in an aqueous medium: (A) said sample; (B) enzyme-bound-ligand, which retains a substantial proportion of its activity when bound to ligand receptor; (C) ligand receptor, wherein said receptor is capable of specifically binding to said ligand and said enzyme-bound-ligand; and (D) enzyme inhibitor, of at least about 5,000 molecular weight which is an enzyme substrate which reacts with said enzyme to inhibit said enzyme and is impeded from reacting with said enzyme when ligand receptor is bound to said enzyme-bound-ligand; and determining the enzymatic activity in said medium as compared to the enzymatic activity in a medium having a known amount of ligand.
Claim 21
Dependent Claim
25 words
A method according to claim 17, wherein said ligand is poly(amino acid) of from about 5,000 to 600,000 molecular weight and said enzyme is peroxidase.
Claim 22
Dependent Claim
22 words
A method according to claim 18, wherein said ligand is γ-globulin and said inhibitor is o-dianisidine bonded to a macromolecular hub nucleus.
Claim 23
Dependent Claim
77 words
An assay composition for use in the method according to claim 1 comprising enzyme-bound-ligand; ligand receptor and enzyme inhibitor of at least 2,000 molecular weight in relative proportions to at least substantially optimize the signal response to analyte, wherein the ratio based on binding sites of ligand receptor to enzyme-bound-ligand will be in the range of about 1-100:1, an equivalent ratio of enzyme-inhibitor to enzyme based on active sites will be in the range of about 0.1-100:1.
Claim 24
Dependent Claim
13 words
An assay composition according to claim 20, wherein said enzyme inhibitor is antienzyme.
Claim 25
Dependent Claim
17 words
An assay composition according to claim 20, wherein said enzyme inhibitor is a macromolecular inhibiting enzyme substrate.
Claim 26
Dependent Claim
60 words
An assay composition for use in the method according to claim 1 for determining antiligand comprising enzyme-bound-ligand and enzyme inhibitor of at least 2,000 molecular weight in relative proportions to at least substantially optimize the signal response to analyte, wherein the equivalent ratio of enzyme inhibitor to enzyme based on active sites will be in the range of about 0.1-100:1.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-11-11 | 1984-05-12 | 1984-11-11 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-11-11 | 1988-05-12 | 1988-11-11 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-11-11 | 1992-05-12 | 1992-11-11 | $7700.00 | Window Closed / Lapsed |